Alimera Enterprise Value Multiple from 2010 to 2024
ALIM Stock | USD 3.97 0.07 1.79% |
Enterprise Value Multiple | First Reported 2010-12-31 | Previous Quarter 22.77849687 | Current Value 23.92 | Quarterly Volatility 15.09129417 |
Check Alimera Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Alimera main balance sheet or income statement drivers, such as Depreciation And Amortization of 9.2 M, Interest Expense of 10.7 M or Selling General Administrative of 11.1 M, as well as many exotic indicators such as Price To Sales Ratio of 1.3, Dividend Yield of 0.0125 or Operating Cycle of 335. Alimera financial statements analysis is a perfect complement when working with Alimera Sciences Valuation or Volatility modules.
Alimera | Enterprise Value Multiple |
Latest Alimera Sciences' Enterprise Value Multiple Growth Pattern
Below is the plot of the Enterprise Value Multiple of Alimera Sciences over the last few years. It is Alimera Sciences' Enterprise Value Multiple historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Alimera Sciences' overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Multiple | 10 Years Trend |
|
Enterprise Value Multiple |
Timeline |
Alimera Enterprise Value Multiple Regression Statistics
Arithmetic Mean | 2.30 | |
Geometric Mean | 5.07 | |
Coefficient Of Variation | 655.93 | |
Mean Deviation | 11.79 | |
Median | (2.38) | |
Standard Deviation | 15.09 | |
Sample Variance | 227.75 | |
Range | 50.574 | |
R-Value | 0.45 | |
Mean Square Error | 194.87 | |
R-Squared | 0.21 | |
Significance | 0.09 | |
Slope | 1.53 | |
Total Sum of Squares | 3,188 |
Alimera Enterprise Value Multiple History
About Alimera Sciences Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Alimera Sciences income statement, its balance sheet, and the statement of cash flows. Alimera Sciences investors use historical funamental indicators, such as Alimera Sciences's Enterprise Value Multiple, to determine how well the company is positioned to perform in the future. Although Alimera Sciences investors may use each financial statement separately, they are all related. The changes in Alimera Sciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Alimera Sciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Alimera Sciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Alimera Sciences. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for 2024 | ||
Enterprise Value Multiple | 22.78 | 23.92 |
Pair Trading with Alimera Sciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alimera Sciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alimera Sciences will appreciate offsetting losses from the drop in the long position's value.Moving against Alimera Stock
0.63 | URGN | UroGen Pharma Financial Report 9th of May 2024 | PairCorr |
0.47 | MMSI | Merit Medical Systems Financial Report 24th of April 2024 | PairCorr |
0.46 | MRK | Merck Company Fiscal Quarter End 31st of March 2024 | PairCorr |
The ability to find closely correlated positions to Alimera Sciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alimera Sciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alimera Sciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alimera Sciences to buy it.
The correlation of Alimera Sciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alimera Sciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alimera Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alimera Sciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Alimera Sciences Correlation against competitors. To learn how to invest in Alimera Stock, please use our How to Invest in Alimera Sciences guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Alimera Stock analysis
When running Alimera Sciences' price analysis, check to measure Alimera Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alimera Sciences is operating at the current time. Most of Alimera Sciences' value examination focuses on studying past and present price action to predict the probability of Alimera Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alimera Sciences' price. Additionally, you may evaluate how the addition of Alimera Sciences to your portfolios can decrease your overall portfolio volatility.
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |
Is Alimera Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alimera Sciences. If investors know Alimera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alimera Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.84) | Revenue Per Share 3.159 | Quarterly Revenue Growth 0.875 | Return On Assets (0.01) | Return On Equity (1.59) |
The market value of Alimera Sciences is measured differently than its book value, which is the value of Alimera that is recorded on the company's balance sheet. Investors also form their own opinion of Alimera Sciences' value that differs from its market value or its book value, called intrinsic value, which is Alimera Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alimera Sciences' market value can be influenced by many factors that don't directly affect Alimera Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alimera Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Alimera Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alimera Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.